Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Hasanuddin University.
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Hasanuddin University; Cerebellum Clinic.
J Rehabil Med. 2023 Feb 27;55:jrm00372. doi: 10.2340/jrm.v55.2572.
Current treatments for osteoarthritis do not resolve the underlying cause. Dextrose prolotherapy is an alternative method that has been proposed for treatment of osteoarthritis, due to its ability to aid tissue regeneration, improve clinical manifestations, and repair damaged tissue structures, which are pathological conditions in osteoarthritis. The aim of this systematic review was to evaluate the efficacy of dextrose prolotherapy compared with other interventions in the management of osteoarthritis.
Electronic databases PubMed, Google Scholar, Cochrane, and BioMed Central were searched from inception to October 2021. Search terms included [(prolotherapy) OR (prolotherapies) OR (dextrose prolotherapy)] AND [(osteoarthritis) OR (osteoarthritides) OR (knee osteoarthritis) OR (hip osteoarthritis) OR (hand osteoarthritis) OR (shoulder osteoarthritis)]. Randomized controlled trials that compared the use of dextrose prolotherapy with other interventions (injection, placebo, therapy, or conservative treatment) in the treatment of osteoarthritis were included. Potential articles were screened for eligibility, and data were extracted by all authors. Risk of bias was assessed using the Cochrane Risk of Bias tool. Study population, methods, and results data were extracted and tabulated by 3 authors.
12 studies reported that DPT was as effective or even more effective in improving functional outcomes compared with other interventions whilst others found that HA, PRP, EP, and ACS were more effective. 14 studies assessed the effectiveness of DPT and ten of them reported that DPT was more effective in reducing pain compared with other interventions.
Dextrose prolotherapy in osteoarthritis confers potential benefits for pain and functional outcomes, but this systematic review found that the studies to date are at high risk of bias.
目前治疗骨关节炎的方法并不能解决其根本原因。葡聚糖注射疗法是一种替代方法,因其具有辅助组织再生、改善临床表现和修复受损组织结构的能力,而这些都是骨关节炎的病理状况,故被提议用于治疗骨关节炎。本系统评价旨在评估葡聚糖注射疗法与其他干预措施在骨关节炎治疗中的疗效。
从建库到 2021 年 10 月,我们检索了电子数据库 PubMed、Google Scholar、Cochrane 和 BioMed Central。检索词包括[(prolotherapy) OR (prolotherapies) OR (dextrose prolotherapy)] AND [(osteoarthritis) OR (osteoarthritides) OR (knee osteoarthritis) OR (hip osteoarthritis) OR (hand osteoarthritis) OR (shoulder osteoarthritis)]。纳入了比较葡聚糖注射疗法与其他干预措施(注射、安慰剂、治疗或保守治疗)治疗骨关节炎的随机对照试验。所有作者对潜在文章进行了筛选以确定其是否符合纳入标准,并提取了数据。使用 Cochrane 偏倚风险工具评估了偏倚风险。由 3 位作者提取和制表了研究人群、方法和结果数据。
12 项研究报告称,与其他干预措施相比,DPT 在改善功能结局方面同样有效,甚至更有效,而其他研究则发现 HA、PRP、EP 和 ACS 更有效。14 项研究评估了 DPT 的有效性,其中 10 项研究报告称 DPT 比其他干预措施更有效地减轻疼痛。
葡聚糖注射疗法在骨关节炎中具有潜在的益处,可改善疼痛和功能结局,但本系统评价发现迄今为止的研究存在较高的偏倚风险。